![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/natco-pharma-on-health-canada-inspection-list-42576.pdf
https://www.business-standard.com/companies/news/usfda-pulls-up-natco-pharma-for-several-violations-at-telangana-plant-124042100125_1.html
https://endpts.com/fda-hits-natco-with-warning-letter-over-india-facility-suspends-product-shipments-to-us/#:~:text=Manufacturer%20Natco%20Pharma%20was%20hit,FDA%20Form%20483%20last%20fall.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/natco-pharma-limited-672564-04082024
https://www.moneycontrol.com/news/business/lupin-glenmark-recall-drugs-in-us-market-usfda-12613191.html
https://www.bseindia.com/xml-data/corpfiling/AttachLive/722561fa-1735-4211-abc3-ea18ccef63ff.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-warning-letter-from-usfda-for-telangana-plant/articleshow/109154234.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf
https://www.indianpharmapost.com/news/natco-invests-us-2-million-in-cellogen-therapeutics-15164